Explore

Rapid Read Rapid Read
University of Pennsylvania Researchers Identify Underreported Side Effects of Weight-Loss Drugs Using AI

University of Pennsylvania Researchers Identify Underreported Side Effects of Weight-Loss Drugs Using AI

Researchers at the University of Pennsylvania have utilized artificial intelligence to analyze over 400,000 Reddit posts, uncovering potential side effects of GLP-1 drugs, such as semaglutide and tirzepatide, which are commonly used for weight loss and diabetes management. The study, published in Nature Health, highlights symptoms that may not be fully documented in clinical trials, including reproductive issues like irregular menstrual cycles and temperature-related effects such as chills and hot flashes. The research points to the value of social media in providing early insights into drug safety, as patients share experiences that may not be captured in traditional clinical settings.
Trendline Trendline
Onchilles Pharma Unveils Promising Preclinical Data for NEU-002 Program at AACR 2026

Onchilles Pharma Unveils Promising Preclinical Data for NEU-002 Program at AACR 2026

Onchilles Pharma Unveils Promising Preclinical Data for NEU-002 Program at AACR 2026
Rapid Read Rapid Read
Study Finds Toothbrushing in Hospitals Reduces Pneumonia Risk

Study Finds Toothbrushing in Hospitals Reduces Pneumonia Risk

A recent study conducted by Brett Mitchell at Avondale University in Australia has revealed that regular toothbrushing among hospital patients can significantly reduce the risk of developing hospital-acquired pneumonia. The study, which is the largest randomized controlled trial of its kind, involved 8,870 patients across three Australian hospitals. Patients who were provided with toothbrushes, toothpaste, and dental care advice were found to be 60% less likely to develop pneumonia compared to those who did not receive these interventions. The study highlights the importance of oral hygiene in preventing pneumonia, a common and deadly healthcare-associated infection. The research was presented at the Congress of the European Society of Clinical Microbiology and Infectious Diseases in Munich, Germany.
Trendline Trendline
NEOK Bio Highlights Bispecific Antibody Drug Conjugate Pipeline at AACR 2026

NEOK Bio Highlights Bispecific Antibody Drug Conjugate Pipeline at AACR 2026

NEOK Bio Highlights Bispecific Antibody Drug Conjugate Pipeline at AACR 2026
Rapid Read Rapid Read
Researchers Explore Menstrual Blood as Potential Treatment for Osteoarthritis

Researchers Explore Menstrual Blood as Potential Treatment for Osteoarthritis

A study published in Scientific Reports has revealed a novel approach to treating osteoarthritis using menstrual blood. Researchers in Lithuania have discovered that extracellular vesicles derived from menstrual blood can stimulate cartilage repair. These vesicles, which are particles released by cells, have the potential to promote regeneration and reduce inflammation. The study involved observing the effects of these vesicles on post-surgical tissue samples from ten female donors with osteoarthritis. The researchers found that the vesicles improved cartilage cell function, slowed tissue degradation, and increased progesterone receptor expression in older cartilage cells. This method could offer a non-invasive alternative to current treatments, which primarily focus on managing pain and inflammation rather than reversing cartilage degeneration.
Rapid Read Rapid Read
AI Analysis Reveals Underreported Side Effects of GLP-1 Weight-Loss Drugs

AI Analysis Reveals Underreported Side Effects of GLP-1 Weight-Loss Drugs

Researchers at the University of Pennsylvania have utilized artificial intelligence to analyze over 400,000 Reddit posts, uncovering potential side effects of GLP-1 drugs, such as semaglutide and tirzepatide, which are commonly used for weight loss and diabetes management. The study, published in Nature Health, identified symptoms like reproductive issues and temperature-related effects that may not be fully documented in clinical trials. The research highlights the value of social media as a source of health-related data, despite its limitations in representativeness. The study emphasizes that while clinical trials are essential, they can be slow, and AI-driven analysis of online discussions can provide faster insights into patient experiences.
Trendline Trendline
Orthogon Therapeutics Secures $11M to Advance BK Virus Antiviral Drug Program

Orthogon Therapeutics Secures $11M to Advance BK Virus Antiviral Drug Program

Orthogon Therapeutics Secures $11M to Advance BK Virus Antiviral Drug Program
Trendline Trendline
Researchers Propose New Obesity Drug Approach, Dropping GLP-1 Target

Researchers Propose New Obesity Drug Approach, Dropping GLP-1 Target

Researchers Propose New Obesity Drug Approach, Dropping GLP-1 Target
Trendline Trendline
Khondrion Begins Phase 3 Trial for Sonlicromanol in Mitochondrial Disease

Khondrion Begins Phase 3 Trial for Sonlicromanol in Mitochondrial Disease

Khondrion Begins Phase 3 Trial for Sonlicromanol in Mitochondrial Disease
Trendline Trendline
Pharmaceutical Industry Embraces Protocol Ingestion to Streamline Clinical Trials

Pharmaceutical Industry Embraces Protocol Ingestion to Streamline Clinical Trials

Pharmaceutical Industry Embraces Protocol Ingestion to Streamline Clinical Trials
Trendline Trendline
Novo Nordisk Gains Edge Over Eli Lilly in Weight-Loss Drug Competition

Novo Nordisk Gains Edge Over Eli Lilly in Weight-Loss Drug Competition

Novo Nordisk Gains Edge Over Eli Lilly in Weight-Loss Drug Competition
Rapid Read Rapid Read
Antihistamine Use Linked to Brain Fog and Cognitive Concerns in Long-Term Users

Antihistamine Use Linked to Brain Fog and Cognitive Concerns in Long-Term Users

A personal account highlights the potential cognitive risks associated with long-term use of first-generation antihistamines, such as diphenhydramine. The narrative describes how the author, Kristina Wright, initially used the medication to manage insomnia during pregnancy and continued its use for 14 years. Despite its effectiveness in aiding sleep, concerns arose when a new doctor suggested that the antihistamine might be contributing to brain fog, previously attributed to menopause. Research by Dr. Shelly Gray from the University of Washington School of Pharmacy indicates that these drugs can cross the blood-brain barrier, affecting neurotransmitters essential for memory and alertness. This disruption, while beneficial for sleep, may lead to cognitive decline with prolonged use.